Skip to main content

Table 4 Details of very late onset reported cases

From: Nontuberculous mycobacterial infection after lung transplantation: a report of four cases

0 References Age Sex Reason fot LuTx LuTx Time to onset Symptoms Chest X-ray findings Culture Pathogen Drug for treatment Outcome
1 1999 Malouf [3] 55 F PAH HL 8.9 years Cough, sputum, dyspnea, fever Normal Sputum MABSC Ri + C + Ci Alive
2    38 M CHD HL 4.3 years Cough, sputum, dyspnea, fever Bilateral apical infiltrate BAL M.avium R + E + C + Ci Alive
3    45 F Empysema SL 3.6 years Cough, sputum, dyspnea, fever Basal infiltrates BAL MAC Ri + C + Ci Alive
4    32 M AATD SL 3.6 years Cough, dyspnea, fever Apical and mid-zone infiltrates Sputum MAC Ri + C + Ci Dead
5    54 M Empysema SL 3.7 years Cough, sputum, dyspnea, fever Consolidation in midzone BAL M.avium No treatment Alive
6    48 M AATD SL 3.3 years Cough, sputum, dyspnea, fever Infiltrate in transpranted lung Pleural fliud M.asiaticum R + E + P Alive
7 2002 Fairhurst [5] 55 F PAH HL 9.0 years Cough, sputum, dyspnea, fever BAL MABSC Ri + C + Ci Alive
8 2006 Chernenko [6] 40 F Eisenmenger HL 9.1 years Fever, chills Sputum MABSC R + C + Ci Dead
9    48 M COPD SL 8.4 years Fever, chills BAL + sputum MABSC R + E + C Dead
10    53 M COPD BL 8.5 years Sputum Normal BAL + sputum MABSC R + E + Ci Alive
11    39 M CF BL 9.3 years Sputum Nodules Sputum MABSC Ri + C + Ci + E Alive
12    42 F LAM BL 4.1 years Sputum Nodules Sputum MABSC AMK + AZ + cefoxitin+Ci Alive
13 2012 Knoll [8] 28 F CF BL 3.2 years BAL M.avium Alive
14 2018 Our study 10 M PAH LDLT 6.3 years None Apical infiltrates BAL M.godnae no treatment Alive
15    35 F BE LDLT 6.8 years Fever, sputum Basal infiltrates BAL MABSC TAZ/PIPC+AZM Alive
16    41 F LAM SL 4.8 years Sputum Basal infiltrates Sputum MABSC AZM + IPM + AMK Alive
  1. AATD α 1-antitrypsin deficiency, AMK amikacin, AZM azithromycin, BAL bronchoalveolar lavage, BE bronchiectasis, BL bilatetal lung, C Clarithromycin, CF cystic fibrosis, CHD congenital heart disease, Ci ciprofloxacin, COPD chronic obstructive pulmonary disease, E Ethambutol, HL heart-lung, IPM imipenem, LAM lymphangioleiomyomatosis, LDLT living donor lung transplantation, P Pyridoxal Phosphate Hydrate, PAH pulmonary arterial hypertension, R rifampicin, Ri Rifabutin, SL single lung, TAZ/PIPC Tazobactam / Piperacillin